Guangzhou Wondfo Biotech revises articles for enhanced governance

Guangzhou Wondfo Biotech has announced a comprehensive revision of its articles of association, effective October 24, 2025, to improve governance and comply with updated laws and regulations. Key changes include clarifying the appointment of legal representatives, adjusting share increase methods, and refining rules for share repurchases, including thresholds and disposal periods. The revised articles also detail shareholder rights, meeting procedures, and the responsibilities of directors and senior management, emphasizing independent director involvement in decision-making.

Furthermore, the company has updated its external guarantee management, related party transaction management, internal audit, and external investment management systems. These revisions focus on strengthening risk control, standardizing approval processes, enhancing information disclosure, and ensuring adherence to legal and regulatory frameworks across all operational aspects, including those involving subsidiaries. The updates reflect a proactive approach to maintaining robust corporate governance and transparent financial practices.